quinoxalines has been researched along with ganglioside, gd2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boratyn, E; Durbas, M; Horwacik, I; Kamycka, E; Rokita, H | 1 |
| Andreeff, M; Bartholomeusz, C; Battula, VL; Hail, N; Nguyen, K; Pitner, MK; Sun, J; Yuan, B | 1 |
| Battula, VL; Nguyen, K | 1 |
3 other study(ies) available for quinoxalines and ganglioside, gd2
| Article | Year |
|---|---|
GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines.
Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Drug Synergism; Gangliosides; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neuroblastoma; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quinolines; Quinoxalines; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases | 2015 |
IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Gangliosides; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Imidazoles; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm Metastasis; Neoplastic Stem Cells; Quinoxalines; RNA Interference; Sialyltransferases; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Targeting NFκB signaling in GD2
Topics: Animals; Cell Line, Tumor; Female; Gangliosides; Humans; Imidazoles; Mice; Molecular Targeted Therapy; Neoplastic Stem Cells; NF-kappa B; Quinoxalines; Sialyltransferases; Signal Transduction; Triple Negative Breast Neoplasms | 2017 |